Pharmaceuticals, Biotechnology & Life Sciences Logo

Working At Progenics Pharmaceuticals

Zippia Score 4.0

Progenics Pharmaceuticals overview

Progenics is focused on developing innovative drugs to improve the lives of prostate cancer patients and their families. Learn more about our therapeutic technologies.
Founded in 1986, Progenics Pharmaceuticals is an established company that loves to hire graduates from Fairleigh Dickinson University, with 11.9% of its employees having attended Fairleigh Dickinson University. Progenics Pharmaceuticals has established itself as a great place to work in New York, and it is number 8 on Zippia's list of Best Companies to Work for in Tarrytown, NY. The average employee at Progenics Pharmaceuticals makes $86,191 per year. Pay at Progenics Pharmaceuticals is significantly lower than some of its highest paying competitors, like MannKind, XBiotech, and Acorda Therapeutics, which pay $103,589, $103,281, and $97,695, respectively.
Based in New York, Progenics Pharmaceuticals is a small technology company with only 58 employees and an annual revenue of $63.6M.

The Organization’s Mission

Progenics Pharmaceuticals, Inc. develops innovative medicines and other technologies to identify, target and treat cancer. Our pipeline includes: (1) therapeutic agents designed to precisely target cancer (AZEDRA and 1095); (2) PSMA-targeted imaging agents for prostate cancer (1404 and PyLTM); and (3) imaging analysis tools. Our first commercial product, RELISTOR (methylnaltrexone bromide) for opioid-induced constipation, is partnered with Valeant. Progenics Pharmaceuticals, Inc. was incorporated in the State of Delaware in 1986.

Industry

Biotechnology

Revenue

$63.6M

Employees

58

Founded in

1986

Headquarters

Tarrytown, NY

Website

progenics.com

Website

progenics.com

Organization Type

Public

Is This Your Company?

The team at Progenics Pharmaceuticals

Key People
  • Kurt Briner (Director)
  • David Scheinberg (Director)
  • Nicole Williams (Director)
  • Peter Crowley (Director)
  • Charles Baker (Director)
  • Robert Israel (Executive Officer)
  • Paul Maddon (Director)
  • Stephen Goff (Director)
  • William Olson (Executive Officer)
  • Mark Baker (Executive Officer, Director)

What do people say about Progenics Pharmaceuticals

Work at Progenics Pharmaceuticals? Share your experience anonymously.

What do you like about working for Progenics Pharmaceuticals?

Progenics Pharmaceuticals Rankings

Progenics Pharmaceuticals is ranked #27 on the Best Technology Companies to Work For in New York list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Progenics Pharmaceuticals Salaries

How much does Progenics Pharmaceuticals pay?
The national average salary for a Progenics Pharmaceuticals employee in the United States is $86,191 per year. Employees in the top 10 percent can make over $132,000 per year, while employees at the bottom 10 percent earn less than $56,000 per year.
8.7
Salary Score
Average Employee Earnings

Progenics Pharmaceuticals Salaries By Job Title

While the average employee salary at Progenics Pharmaceuticals is $86,191, there is a big variation in pay depending on the role. Some of the positions that earn high wages at Progenics Pharmaceuticals include Operations Manager, Platoon Sergeant, Staff Sergeant, and Lead Engineer. A worker with the title Operations Manager salary at Progenics Pharmaceuticals can earn an average yearly salary of $120,640. Other roles at Progenics Pharmaceuticals include Maintenance Supervisor and Electronics Technician. A Maintenance Supervisor at Progenics Pharmaceuticals earns an average yearly salary of $33,943.
RankTitleAverage
1
Operations Manager
$120,640
2
Platoon Sergeant
$116,493
3
Staff Sergeant
$116,377
4
Lead Engineer
$115,449
5
Squad Leader
$112,742

Progenics Pharmaceuticals careers

On average, employees at Progenics Pharmaceuticals stay with the company for 3.9 years. Employees most commonly join Progenics Pharmaceuticals after leaving Novartis. When they leave Progenics Pharmaceuticals, they most frequently get their next job at Pfizer.

Average Length of Employment

Progenics Pharmaceuticals

3.9 years
Genentech3.0 years
Top Employers Before Progenics Pharmaceuticals
Novartis12.7 %
Pfizer8.2 %
Show More
Top Employers After Progenics Pharmaceuticals
Pfizer12.7 %
Show More
00

Do you Work At Progenics Pharmaceuticals?

Help us make this company more transparent.

0

Progenics Pharmaceuticals Financial Performance

6.5
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

$10M - $100M

Founded in

1986

Organization type

Public

How Would You Rate The Company Culture Of Progenics Pharmaceuticals?

Have you worked at Progenics Pharmaceuticals? Help other job seekers by rating Progenics Pharmaceuticals.

Progenics Pharmaceuticals Competitors

Competitors of Progenics Pharmaceuticals include MannKind Corporation, XBiotech, and Acorda Therapeutics. The average salaries at MannKind Corporation rank the highest, with their employees earning an average salary of $103,589 per year. Employees at XBiotech earn an average of $103,281 per year, and the employees at Acorda Therapeutics earn an average salary of $97,695 per year.

Frequently Asked Questions about Progenics Pharmaceuticals

When was Progenics Pharmaceuticals founded?

Progenics Pharmaceuticals was founded in 1986.

How many Employees does Progenics Pharmaceuticals have?

Progenics Pharmaceuticals has 58 employees.

How much money does Progenics Pharmaceuticals make?

Progenics Pharmaceuticals generates $63.6M in revenue.

What industry is Progenics Pharmaceuticals in?

Progenics Pharmaceuticals is in the biotechnology industry.

What is Progenics Pharmaceuticals's mission?

Progenics Pharmaceuticals's mission statement is "Progenics Pharmaceuticals, Inc. develops innovative medicines and other technologies to identify, target and treat cancer. Our pipeline includes: (1) therapeutic agents designed to precisely target cancer (AZEDRA and 1095); (2) PSMA-targeted imaging agents for prostate cancer (1404 and PyLTM); and (3) imaging analysis tools. Our first commercial product, RELISTOR (methylnaltrexone bromide) for opioid-induced constipation, is partnered with Valeant. Progenics Pharmaceuticals, Inc. was incorporated in the State of Delaware in 1986."

What type of company is Progenics Pharmaceuticals?

Progenics Pharmaceuticals is a public company.

Who are Progenics Pharmaceuticals's competitors?

Progenics Pharmaceuticals competitors include BioMarin Pharmaceutical Inc., Seattle Genetics, Genentech, Acorda Therapeutics, Gilead Sciences, Amicus Therapeutics, Celgene, Exelixis, Im Clone Systems Inc., Centocor, MannKind Corporation, Genzyme, Novavax, Alkermes, XBiotech, Immunomedics Inc., Science Systems and Applications, Vericel, Emergent BioSolutions, Ionis Pharmaceuticals.

Who works at Progenics Pharmaceuticals?

Kurt Briner (Director)

David Scheinberg (Director)

Nicole Williams (Director)

Show More

Are you an executive, HR leader, or brand manager at Progenics Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Progenics Pharmaceuticals, also known as PROGENICS PHARM INC, PROGENICS PHARMACEUTICALS INC, Progenics Pharmaceuticals, Progenics Pharmaceuticals Inc and Progenics Pharmaceuticals, Inc..

Zippia gives an in-depth look into the details of Progenics Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Progenics Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Progenics Pharmaceuticals. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Progenics Pharmaceuticals and its employees or that of Zippia.